Rome, Italy

Stefania Capone

USPTO Granted Patents = 5 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Stefania Capone, Pioneering Scientific Breakthroughs in Rome

Introduction:

Stefania Capone, a visionary inventor based in Rome, Italy, has left an indelible mark in the field of biotechnology with her groundbreaking patents and contributions to medical research.

Latest Patents:

1. Adenovirus Polynucleotides and Polypeptides: Capone's innovative work revolves around isolated polynucleotide and polypeptide sequences derived from the novel chimpanzee adenovirus ChAd157. Her patented invention includes recombinant polynucleotides, vectors, adenoviruses, cells, and compositions containing these sequences.

2. Epstein-Barr Virus Antigen Constructs: Capone's inventive Epstein-Barr Virus antigen polynucleotides, polypeptides, and vectors pave the way for immunogenic compositions, with a focus on developing vaccines for treating and preventing Epstein-Barr Virus infections and associated diseases like multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus.

Career Highlights:

Employed at GlaxoSmithKline Biologicals SA, a renowned pharmaceutical company, Capone has harnessed her expertise to drive innovation and lead cutting-edge research projects in the realm of biopharmaceuticals.

Collaborations:

Capone's exemplary work has been further enriched through collaborations with esteemed colleagues such as Antonella Folgori and Virginia Ammendola, reflecting her commitment to teamwork and knowledge-sharing in the pursuit of scientific advancement.

Conclusion:

In conclusion, Stefania Capone's profound dedication to pioneering scientific discovery and her invaluable contributions to the field of biotechnology exemplify the essence of innovation and its transformative power in shaping the future of healthcare and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…